Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
about
Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected childrenGetting to 90-90-90 in paediatric HIV: What is needed?A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru.Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON®-Gold Testing.Drug-Induced Liver Injury in Children: Clinical Observations, Animal Models, and Regulatory Status.The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
P2860
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Rifamycins (rifampicin, rifabu ...... e people at risk of active TB.
@en
type
label
Rifamycins (rifampicin, rifabu ...... e people at risk of active TB.
@en
prefLabel
Rifamycins (rifampicin, rifabu ...... e people at risk of active TB.
@en
P2093
P2860
P356
P1476
Rifamycins (rifampicin, rifabu ...... ve people at risk of active TB
@en
P2093
Anju Sharma
Prathap Tharyan
Surendra K Sharma
P2860
P304
P356
10.1002/EBCH.1962
P577
2014-03-01T00:00:00Z